Georgia M. Beasley

3.1k total citations · 1 hit paper
121 papers, 1.8k citations indexed

About

Georgia M. Beasley is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Georgia M. Beasley has authored 121 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 102 papers in Oncology, 40 papers in Molecular Biology and 39 papers in Immunology. Recurrent topics in Georgia M. Beasley's work include Cutaneous Melanoma Detection and Management (64 papers), CAR-T cell therapy research (43 papers) and Immunotherapy and Immune Responses (33 papers). Georgia M. Beasley is often cited by papers focused on Cutaneous Melanoma Detection and Management (64 papers), CAR-T cell therapy research (43 papers) and Immunotherapy and Immune Responses (33 papers). Georgia M. Beasley collaborates with scholars based in United States, United Kingdom and Spain. Georgia M. Beasley's co-authors include Douglas S. Tyler, April K.S. Salama, Paul J. Mosca, Jonathan S. Zager, Christina K. Augustine, Brent A. Hanks, Norma E. Farrow, Nicole McMahon, Merrick I. Ross and Scott K. Pruitt and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Georgia M. Beasley

114 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A lactate-SREBP2 signaling axis drives tolerogenic dendritic cell maturation and promotes cancer progression

2024 59 citations Michael P. Plebanek, Nicholas C. DeVito et al. profile →

Peers

Countries citing papers authored by Georgia M. Beasley

Since Specialization

Citations

This map shows the geographic impact of Georgia M. Beasley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Georgia M. Beasley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Georgia M. Beasley more than expected).

Fields of papers citing papers by Georgia M. Beasley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Georgia M. Beasley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Georgia M. Beasley. The network helps show where Georgia M. Beasley may publish in the future.

Co-authorship network of co-authors of Georgia M. Beasley

This figure shows the co-authorship network connecting the top 25 collaborators of Georgia M. Beasley. A scholar is included among the top collaborators of Georgia M. Beasley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Georgia M. Beasley. Georgia M. Beasley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	GLI2 Facilitates Tumor Immune Evasion and Immunotherapeutic Resistance by Coordinating WNT and Prostaglandin Signaling 2025 ·Cancer Research ·Nicholas C. DeVito, (unknown), (unknown), Michael P. Plebanek, (unknown), Nagendra Sastry Yarla, Vaibhav Jain, (unknown), Georgia M. Beasley, Balamayooran Theivanthiran, Brent A. Hanks	1
2	Adjuvant Therapy for Melanoma 2024 ·Surgical Clinics of North America ·(unknown), (unknown), Kristen E. Rhodin, Georgia M. Beasley	0
3	Abstract CT053: Merlin_001: a prospective registry study of a primary melanoma gene-signature to predict sentinel node (SN) status and determine its prognostic value for more accurate staging of SN-negative melanoma patients 2023 ·Cancer Research ·Tina J. Hieken, Michael E. Egger, Christina V. Angeles, Erin E. Burke, Michael Lowe, John Hyngstrom, Georgia M. Beasley, Edmund K. Bartlett, Vernon K. Sondak	2
4	Survey Study of Clerkship Curriculum on Learner's Choice to Pursue Surgery: Positive Impact of Extracurricular Opportunities 2023 ·Journal of surgical education ·Yoshiko Iwai, Alice Yunzi L. Yu, Samantha M. Thomas, Carolyn Quinsey, Georgia M. Beasley, Ranjan Sudan, Oluwadamilola M. Fayanju	1
5	Intratumor childhood vaccine-specific CD4⁺ T-cell recall coordinates antitumor CD8⁺ T cells and eosinophils 2023 ·Journal for ImmunoTherapy of Cancer ·Michael C. Brown, Georgia M. Beasley, (unknown), Yuanfan Yang, Annick Desjardins, Dina Randazzo, Daniel Landi, David M. Ashley, Darell D. Bigner, Smita K. Nair, Matthias Gromeier	4
6	Spatial biology analysis reveals B cell follicles in secondary lymphoid structures may regulate anti-tumor responses at initial melanoma diagnosis 2022 ·Frontiers in Immunology ·(unknown), Georgia M. Beasley, Kristen E. Rhodin, Norma E. Farrow, Douglas S. Tyler, David Boczkowski, Rami N. Al‐Rohil, Eda K. Holl, Smita K. Nair	3
7	Tumor-intrinsic NLRP3-HSP70-TLR4 axis drives premetastatic niche development and hyperprogression during anti–PD-1 immunotherapy 2022 ·Science Translational Medicine ·Balamayooran Theivanthiran, (unknown), Tarek Haykal, (unknown), (unknown), Michelle Ferreira, Alisha Holtzhausen, Rami N. Al‐Rohil, April K.S. Salama, Georgia M. Beasley, Michael P. Plebanek, Nicholas C. DeVito, Brent A. Hanks	34
8	Examining the role of wide excision margins in pediatric melanoma: A National Cancer Database analysis 2022 ·Pediatric Blood & Cancer ·Norma E. Farrow, Jina Kim, Steven E. Wolf, Samantha M. Thomas, (unknown), Paul J. Mosca, Georgia M. Beasley, Elisabeth T. Tracy	2
9	Regional control after precision lymph node dissection for clinically evident melanoma metastasis 2022 ·Journal of Surgical Oncology ·Kevin Lynch, Yinin Hu, Norma E. Farrow, Yun Song, Max O. Meneveau, Minyoung Kwak, Michael Lowe, Edmund K. Bartlett, Georgia M. Beasley, Giorgos C. Karakousis, Craig L. Slingluff	1
10	Viral infection of cells within the tumor microenvironment mediates antitumor immunotherapy via selective TBK1-IRF3 signaling 2021 ·Nature Communications ·Michael C. Brown, Mubeen Mosaheb, Malte Mohme, (unknown), Eda K. Holl, (unknown), Yuanfan Yang, Georgia M. Beasley, Esther Hwang, David M. Ashley, Darell D. Bigner, Smita K. Nair, Matthias Gromeier	50
11	How much time is enough? Sentinel lymph node mapping time depends on the radiotracer agent 2021 ·Journal of Surgical Oncology ·(unknown), Norma E. Farrow, (unknown), (unknown), Charles Intenzo, (unknown), Douglas S. Tyler, Adam C. Berger, Georgia M. Beasley	2
12	Acral Lentiginous Melanoma: A United States Multi-Center Substage Survival Analysis 2021 ·Cancer Control ·(unknown), Gerardo A. Vitiello, Erica B. Friedman, James Sun, (unknown), (unknown), Norma E. Farrow, Clara R. Farley, John T. Vetto, Dale Han, (unknown), Georgia M. Beasley, Carlo M. Contreras, Michael Lowe, Jonathan S. Zager, Iman Osman, Russell S. Berman, Tracey N. Liebman, Jennifer Stein, Ann Y. Lee	16
13	Ipilimumab and Radiation in Patients with High-risk Resected or Regionally Advanced Melanoma 2020 ·Clinical Cancer Research ·April K.S. Salama, Manisha Palta, Christel Rushing, M. Angélica Selim, Kristen N. Linney, Brian G. Czito, David S. Yoo, Brent A. Hanks, Georgia M. Beasley, Paul J. Mosca, (unknown), (unknown), John S. Yi, Kent J. Weinhold, Douglas S. Tyler, Walter T. Lee, David M. Brizel	4
14	The utility of initial staging PET-CT as a baseline scan for surveillance imaging in stage II and III melanoma 2020 ·Surgical Oncology ·(unknown), (unknown), David C. Jones, (unknown), Visakha Suresh, (unknown), Brent A. Hanks, Georgia M. Beasley, April K.S. Salama, Brandon A. Howard, Paul J. Mosca	4
15	Retreatment with Talimogene Laherparepvec for Advanced Melanoma 2020 ·Immunotherapy ·(unknown), Sabran Masoud, (unknown), Georgia M. Beasley, Paul J. Mosca	1
16	The Landmark Series: Regional Therapy of Recurrent Cutaneous Melanoma 2019 ·Annals of Surgical Oncology ·Georgia M. Beasley, Jonathan S. Zager, John F. Thompson	3
17	Does the number of sentinel lymph nodes removed affect the false negative rate for head and neck melanoma? 2018 ·Journal of Surgical Oncology ·(unknown), Srirama Josyula, Alicia M. Terando, John H. Howard, Doreen M. Agnese, Paul J. Mosca, Walter T. Lee, Georgia M. Beasley	14
18	The impact of transplant rejection on cutaneous squamous cell carcinoma in renal transplant recipients 2018 ·Clinical and Experimental Dermatology ·(unknown), (unknown), Adela R. Cardones, Georgia M. Beasley, Paul J. Mosca	0
19	Bevacizumab-Induced Alterations in Vascular Permeability and Drug Delivery: A Novel Approach to Augment Regional Chemotherapy for In-Transit Melanoma 2012 ·Clinical Cancer Research ·Ryan S. Turley, Andrew N. Fontanella, James C. Padussis, (unknown), Yoshihiro Tokuhisa, Eugenia H. Cho, Gabi Hanna, Georgia M. Beasley, Christina K. Augustine, Mark W. Dewhirst, Douglas S. Tyler	48
20	Sorafenib, a Multikinase Inhibitor, Enhances the Response of Melanoma to Regional Chemotherapy 2010 ·Molecular Cancer Therapeutics ·Christina K. Augustine, (unknown), Sin‐Ho Jung, Patricia A. Zipfel, Jin Soo Yoo, Yasunori Yoshimoto, M. Angélica Selim, James L. Burchette, Georgia M. Beasley, Nicole McMahon, James C. Padussis, Scott K. Pruitt, Francis Ali‐Osman, Douglas S. Tyler	35

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact